Statistical evaluation of in vitro dissolution of different brands of ciprofloxacin hydrochloride tablets and capsules

Drug Development and Industrial Pharmacy

Volumn 24, Issue 6, 1998, Pages 549-552

  Tang, Yeqiu ^a   Gan, Kesu ^a  

^a Changshu No1 People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ARTICLE; CHINA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG MANUFACTURE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; INTESTINE ABSORPTION; STATISTICAL ANALYSIS;

EID: 0031747422     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049809085656     Document Type: Article

References (4)

1. L. G. Amidon, H. Lennernas, V. P. Shah, and J. R. A. Crison, Theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res., 12(3), 413-420 (1995).
2. J. Cohen, et al., The development of USP dissolution and drug release standards, Pharm. Res., 7(10), 983-987 (1990)
3. U. V, Banakar, C. D. Lathia, and J. H. Wood, Interpretation of dissolution rate data and techniques of in vivo dissolution, in Pharmaceutical Dissolution Testing (U. V. Banakar, ed.), Marcel Dekker, Inc., New York, 1992, pp. 202-203.
4. A. Rudman, et al., Guidance for industry: immediate-release solid dosage forms/scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing; in vivo bioequivalence documentation, Pharm. Technol., 20(3), 50-233 (1996).